1. Delivering PrEP to Young Women in a Low-Income Setting in South Africa: Lessons for Providing Both Convenience and Support
- Author
-
Sarah Jane Steele, Nikiwe Malabi, Nelisiwe Ntuli, Laura Trivino Duran, Charllen Kilani, Tom Ellman, Aurelie Nelson, C. Pfaff, Rebecca O’Connell, Tali Cassidy, Tabitha Mutseyekwa, Bulelwa Rorwana, Virginia De Azevedo, and Zee Ndlovu
- Subjects
Adult ,Low income ,medicine.medical_specialty ,Adolescent ,Social Psychology ,Anti-HIV Agents ,HIV prevention ,HIV Infections ,030204 cardiovascular system & hematology ,Medication Adherence ,law.invention ,South Africa ,Young Adult ,03 medical and health sciences ,Pre-exposure prophylaxis ,Social support ,0302 clinical medicine ,Condom ,law ,medicine ,Humans ,030212 general & internal medicine ,Original Paper ,business.industry ,Public health ,Public Health, Environmental and Occupational Health ,Correction ,Health psychology ,Infectious Diseases ,Adherence ,Pill ,Facilitator ,Family medicine ,Africa ,Female ,Young women ,business - Abstract
Daily oral pre-exposure prophylaxis (PrEP) is a key tool in addressing high HIV incidence among young women, and breaking the cycle of transmission. From 2017 to 2020, Médecins Sans Frontières (MSF) offered PrEP, in conjunction with contraception and risk-reduction counselling, to women aged 18–25, in a government-run clinic in Khayelitsha, a low income high HIV prevalence area in South Africa. Drawing on clinical, quantitative, and qualitative interview data, we describe participants’ experiences and engagement with the PrEP program, participant adherence (measured by TFV-DP levels in dried blood spots) over time, and the indirect benefits of the PrEP program. Of 224 screened and eligible participants, 164 (73.2%) initiated PrEP, with no large differences between those who initiated and those who did not. Overall, 47 (29%) completed 18 months follow-up, with 15 (9.1%) attending all visits. 76 (46.9%) participants were lost to follow-up, 15 (9.1%) exited when leaving the area, and 28.7% of exits happened in the first month of the study. We identified two different trajectories of PrEP adherence: 67% of participants had, on average, consistently low TFV-DP levels, with the remaining 33% having sustained high adherence. Few baseline characteristics predicted good adherence. The main reported barrier to taking PrEP was forgetting to take or travel with the pills. Encouragement from others declined as a reported facilitator from month 6 to 18 (family: 93.1% vs 77.6%, p = 0.016, friends: 77.6% vs 41.4%, p ≤ 0.001, partners: 62.1% vs 46.6%, p = 0.096, other PrEP users: 89.7% vs 74.1%, p = 0.020). Disclosure to friends and family in some cases opened dialogue around sex, and helped to educate others about PrEP. Self-reported sex with more than one partner, and sex without a condom, decreased significantly after enrolment (p
- Published
- 2021